related agents (primarily G03, also L02, H01C) - human endogenous in CAPSProgestogens:(receptor) PROGESTERONE,Dienogest, Desogestrel, Drospirenone, Dydrogesterone, Ethisterone, Etonogestrel, Ethynodiol diacetate, casodex priapism Gestonorone, Levonorgestrel, Lynestrenol, Medroxyprogesterone, Megestrol, Norelgestromin, Norethisterone.

number 90357-06-5ATC code L02BB03PubChem 56069DrugBank APRD00042Chemical dataFormula C18H14F4N2O4SMol. mass 430.374 g/molPharmacokinetic dataBioavailability well absorbedProtein binding 96%Metabolism hepaticHalf life 5.8 daysExcretion ?Therapeutic considerationsPregnancy casodex priapism X(US)Legal status ? Prescription onlyRoutes OralBicalutamide (marketed as Casodex®, Cosudex®, Calutide®, Kalumid®) is an oral non-steroidal anti-androgen with the brand names Casodex and Cosudex. casodex priapism casodex priapism recommended 50 mg once daily in combination with an casodex priapism analogue or casodex priapism a monotherapy. Has been used in clinical trials for ovarian casodex priapism Contraindications and precautions4 Adverse reactions5 External links[edit] DescriptionBicalutamide is an oral non-steroidal anti-androgen with the brand names Casodex and Cosudex. Bicalutamide is recommended 50 mg once daily in combination with an LHRH analogue or as a monotherapy. Has been used in clinical trials for ovarian cancer.[edit] casodex priapism and.

of stage casodex priapism metastatic prostate cancer and subsequently launched as monotherapy for the treatment of stage D2 metastatic prostate cancer metastatic.